Open AccessThe Value of Shashen Maidong Decoction in the Treatment of Advanced Lung Cancer
Author(s) -
Limei Qin
Publication year - 2021
Publication title -
proceedings of anticancer research
Language(s) - English
Resource type - Journals
eISSN - 2208-3553
pISSN - 2208-3545
DOI - 10.26689/par.v5i5.2490
Subject(s) - medicine , decoction , lung cancer , gastroenterology , adverse effect , chemotherapy , incidence (geometry) , cancer , surgery , optics , physics
Objective: This study mainly explores the clinical effect of Shashen Maidong Decoction in the treatment of advanced lung cancer. Methods: Twelve patients with advanced lung cancer from Inner Mongolia Baicaotang Qin’s Zhong Meng Medical Hospital were randomly selected from February 2016 to February 2021. They were divided into two groups: the reference group and study group by the digital table method. The reference group was treated with conventional chemotherapy while the study group was treated with Shashen Maidong Decoction plus conventional chemotherapy. Results: The remission rate of the study group was higher than that of the reference group, and the incidence of adverse reactions was lower than that of the reference group, P < 0.05. The levels of CD3+, CD4+, and CD4+/CD8+ in the study group were higher than those in the reference group (P < 0.05). After treatment, the quality of life score of the study group was higher than that of the reference group (P < 0.05). Conclusion: Shashen Maidong Decoction can effectively reduce adverse reactions and improve the condition of patients in the treatment of advanced lung cancer.